EVH - Evolent Health, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$6.30
DETAILS
HIGH:
$10.00
LOW:
$3.50
MEDIAN:
$6.00
CONSENSUS:
$6.30
UPSIDE:
59.49%
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||
| Revenue | 1,876.2 | 2,554.7 | 1,963.9 | 1,352.0 | 908.0 | 924.6 | 687.1 | 627.1 | 434.9 | 254.2 | 96.9 | 0 | 25.7 | 8.3 |
| Cost of Revenue | 1,592.2 | 2,187.4 | 1,503.4 | 1,035.4 | 657.6 | 696.6 | 513.0 | 327.8 | 269.4 | 155.2 | 57.4 | 0 | 30.0 | 11.3 |
| Gross Profit | 284.0 | 367.4 | 460.5 | 316.6 | 250.4 | 228.1 | 174.1 | 299.2 | 165.6 | 99.0 | 39.5 | 0 | (4.3) | (2.9) |
| Operating Expenses | ||||||||||||||
| R&D Expenses | 0 | 0 | 0 | 27 | 0 | 0 | 0 | 18.2 | 17.2 | 11.1 | 5.8 | 0 | 2 | 0 |
| SG&A Expenses | 288.5 | 263.1 | 358.1 | 269.3 | 219.5 | 210.4 | 236.4 | 306.3 | 205.7 | 160.7 | 75.3 | 0 | 15.6 | 16.0 |
| Other Expenses | 0 | 144.8 | 173.6 | 16.7 | 73.3 | 280.5 | 246.5 | 0.1 | 0.2 | 0.0 | 7.2 | (25.2) | 0.0 | 0 |
| Operating Expenses | 288.5 | 407.8 | 531.7 | 312.9 | 292.8 | 490.9 | 483.0 | 350.8 | 238.0 | 177.9 | 82.5 | (25.2) | 16.8 | 16.7 |
| Operating Income | ||||||||||||||
| Operating Income | (4.4) | (40.5) | (71.2) | 3.6 | (42.4) | (262.8) | (308.9) | (47.5) | (72.8) | (237.4) | (43.0) | (25.2) | (21.2) | (19.6) |
| Interest Expense | 57.5 | 24.7 | 54.2 | 15.6 | 25.4 | 28.3 | 14.6 | 5.5 | 3.6 | 0.7 | 0.3 | 0 | 0.8 | 0 |
| Interest Income | 4.2 | 5.5 | 5.3 | 1.4 | 0.4 | 2.6 | 3.4 | 3.4 | 1.7 | 0 | 0 | 0 | 0 | 0.0 |
| Profitability | ||||||||||||||
| EBITDA | 111.4 | 84.9 | (24.8) | 43.7 | 55.7 | (240.7) | (254.5) | (4.2) | (40.4) | (220.3) | (31.5) | (25.2) | (20.3) | (19.5) |
| EBIT | (4.4) | (38.3) | (148.2) | (46.5) | (4.4) | (302.2) | (315.4) | (48.7) | (72.8) | (237.3) | 343.3 | (25.2) | (21.2) | (19.6) |
| Income Before Tax | (534.6) | (63.0) | (202.4) | (62.1) | (29.8) | (330.5) | (330.0) | (54.2) | (76.4) | (237.5) | 343.3 | (25.2) | 20.0 | (19.6) |
| Income Tax Expense | (0.1) | (1.4) | (89.4) | (43.4) | 0.5 | (2.4) | (22.8) | 0.0 | (6.6) | (10.8) | 23.5 | 0 | 0.0 | (0.3) |
| Net Income | (534.5) | (61.6) | (113.0) | (19.2) | (37.6) | (334.2) | (302.0) | (52.7) | (60.7) | (159.7) | 332.5 | (25.2) | 20.0 | (19.3) |
| Per Share Data | ||||||||||||||
| EPS (Basic) | -5.07 | -0.81 | -1.28 | -0.20 | -0.36 | -3.94 | -3.71 | -0.68 | -0.94 | -3.55 | 8.03 | -0.66 | 0.06 | -0.50 |
| EPS (Diluted) | -5.07 | -0.81 | -1.28 | -0.20 | -0.36 | -3.94 | -3.71 | -0.68 | -0.94 | -3.55 | 7.21 | -0.66 | 0.06 | -0.50 |
| Shares Outstanding | 114.2 | 114.7 | 111.3 | 93.7 | 86.1 | 84.9 | 82.4 | 77.3 | 64.4 | 45.0 | 41.4 | 38.2 | 38.2 | 38.2 |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Current Assets | ||||||||||
| Cash & Cash Equivalents | 151.9 | 104.2 | 192.8 | 188.2 | 266.3 | 333.4 | 101.0 | 228.3 | 238.4 | 134.6 |
| Short-Term Investments | 0 | 59.3 | 0 | 0 | 0 | 0 | 1.8 | 0 | 0 | 44.3 |
| Net Receivables | 323.4 | 414.7 | 446.7 | 254.7 | 130.6 | 124.4 | 77.4 | 82.3 | 68.9 | 40.6 |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 78.5 | (3.3) | (40.6) |
| Other Current Assets | 31.1 | 28.9 | 44.1 | 35.2 | 75.7 | 89.9 | 20.1 | 154.7 | 62.4 | 34.4 |
| Total Current Assets | 506.4 | 607.1 | 683.7 | 478.1 | 524.0 | 547.6 | 228.8 | 488.0 | 378.2 | 265.0 |
| Non-Current Assets | ||||||||||
| Property, Plant & Equipment | 85.2 | 79.3 | 90.2 | 136.9 | 131.6 | 144.0 | 157.3 | 73.6 | 50.9 | 31.2 |
| Goodwill | 694.5 | 1,137.3 | 1,116.5 | 722.8 | 426.3 | 349.0 | 572.1 | 768.1 | 628.2 | 626.6 |
| Intangible Assets | 584.9 | 680.2 | 752.0 | 442.8 | 279.8 | 265.0 | 308.5 | 335.0 | 241.3 | 258.9 |
| Long-Term Investments | 9.0 | 8.6 | 4.9 | 4.5 | 5.5 | 17.7 | 139.4 | 10.0 | 1.5 | 2.2 |
| Other Non-Current Assets | 19.3 | 31.9 | 33.0 | 32.3 | 52.4 | 48.3 | 92.0 | 6.1 | 3.3 | 6 |
| Total Non-Current Assets | 1,392.9 | 1,937.3 | 1,996.6 | 1,339.2 | 895.5 | 926.8 | 1,269.2 | 1,113.2 | 869.4 | 885.5 |
| Total Assets | 1,899.2 | 2,544.4 | 2,680.3 | 1,817.3 | 1,419.5 | 1,474.4 | 1,498.0 | 1,722.3 | 1,312.7 | 1,199.8 |
| Current Liabilities | ||||||||||
| Account Payables | 59.8 | 96.0 | 48.2 | 57.2 | 96.1 | 32.0 | 37.5 | 146.8 | 42.9 | 43.9 |
| Short-Term Debt | 15.3 | 171.5 | 0 | 0 | 0 | 33.9 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 1.2 | 2.5 | 6.0 | 5.8 | 11.9 | 10.2 | 19.8 | 20.6 | 24.8 | 20.5 |
| Other Current Liabilities | 308.9 | 352.4 | 460.4 | 252.2 | 223.2 | 280.1 | 95.8 | 76.6 | 29.6 | 29.2 |
| Total Current Liabilities | 385.3 | 715.5 | 674.2 | 433.4 | 445.5 | 403.3 | 192.8 | 146.8 | 132.7 | 131.9 |
| Non-Current Liabilities | ||||||||||
| Long-Term Debt | 970.5 | 490.5 | 597.0 | 413.0 | 215.7 | 263.3 | 293.7 | 221.0 | 121.4 | 120.3 |
| Deferred Tax Liabilities | 7.5 | 119.0 | 121.2 | 50.7 | 1.4 | 103.4 | 1.9 | 25.4 | 2.4 | 20.8 |
| Other Non-Current Liabilities | 116.8 | 193.2 | 182.1 | 4.7 | 5.5 | 18.7 | 11.7 | 17.1 | 9.9 | 14.7 |
| Total Non-Current Liabilities | 1,098.8 | 827.7 | 938.4 | 524.4 | 280.3 | 451.5 | 376.2 | 386.2 | 121.4 | 120.3 |
| Total Liabilities | 1,484.0 | 1,543.2 | 1,612.6 | 957.9 | 725.8 | 854.8 | 569.0 | 532.9 | 266.4 | 287.7 |
| Stockholders' Equity | ||||||||||
| Common Stock | 1.2 | 1.2 | 1.2 | 1.0 | 0.9 | 0.9 | 0.8 | 0.8 | 0.8 | 0.7 |
| Retained Earnings | (1,315.3) | (780.8) | (719.2) | (606.2) | (626.8) | (589.2) | (252.0) | 50.0 | 86.0 | 146.6 |
| Accumulated Other Comprehensive Income | (2.6) | (1.8) | (1.3) | (1.2) | (0.4) | (0.3) | (0.2) | (0.2) | (14.5) | (5.2) |
| Total Stockholders' Equity | 415.2 | 1,001.3 | 1,067.7 | 859.4 | 693.6 | 619.6 | 922.4 | 1,143.8 | 1,010.9 | 702.5 |
| Total Liabilities & Equity | 1,899.2 | 2,544.4 | 2,680.3 | 1,817.3 | 1,419.5 | 1,474.4 | 1,498.0 | 1,722.3 | 1,312.7 | 1,199.8 |
| Debt Metrics | ||||||||||
| Total Debt | 989.7 | 713.7 | 644.8 | 476.1 | 280.5 | 359.8 | 368.8 | 221.0 | 121.4 | 120.3 |
| Net Debt | 837.8 | 609.5 | 452.0 | 287.9 | 14.2 | 26.4 | 267.8 | (7.3) | (117.0) | (14.3) |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||
| Net Income | (579.4) | (61.6) | (113.0) | (19.2) | (37.6) | (328.2) | (302.0) | (54.2) | (69.8) | (226.8) |
| Depreciation & Amortization | 122.6 | 125.6 | 123.4 | 67.2 | 60.0 | 60.8 | 66.6 | 44.5 | 32.4 | 17.2 |
| Stock-Based Compensation | 39.7 | 39.7 | 40.5 | 34.0 | 16.7 | 0 | 0 | 17.6 | 20.4 | 22.5 |
| Change in Working Capital | (57.4) | (116.6) | 21.9 | (104.4) | (22.5) | (55.3) | 0.3 | (34.9) | (7.3) | (4.4) |
| Other Non-Cash Items | 516.2 | 34.4 | 101.1 | 10.5 | 22.6 | 307.6 | 215.5 | 6.2 | 3.6 | 166.7 |
| Operating Cash Flow | 38.8 | 18.8 | 142.6 | (11.6) | 38.7 | (16.2) | (42.6) | (20.7) | (28.0) | (35.5) |
| Investing Activities | ||||||||||
| Capital Expenditure | (34.1) | (24.9) | (28.7) | (38.4) | (25.0) | (29.5) | (35.5) | (39.5) | (27.8) | (15.5) |
| Acquisitions | 0 | 0 | 0.9 | 5.6 | 14.2 | (0.3) | (8.6) | (139.6) | (4.8) | (85.6) |
| Purchases of Investments | (1) | (7.3) | 0 | (5.6) | (3.0) | (11.2) | (99.1) | (10.0) | (3.8) | (9.1) |
| Sales/Maturities of Investments | 0 | 0 | 0 | 5.6 | 0.5 | 143.4 | 2.6 | 0.3 | 44.2 | 9.4 |
| Other Investing Activities | 34.9 | (30.7) | (387.7) | (226.3) | (2.5) | 160.9 | (41) | 28.4 | (20) | (6.1) |
| Investing Cash Flow | (0.2) | (62.9) | (415.5) | (259.1) | (15.8) | 261.1 | (181.6) | (160.4) | (12.3) | (97.8) |
| Financing Activities | ||||||||||
| Net Debt Issuance | 65.1 | 58.6 | 183.3 | 219.7 | (37.7) | 13.5 | 62.6 | 167.2 | 0 | 121.2 |
| Stock Repurchased | (40.0) | 0 | 0 | (18.3) | 0 | 0 | 0 | (1.2) | 0 | (0.4) |
| Dividends Paid | (11.1) | (20.1) | (18.8) | 0 | (1.3) | (20) | 0 | 0 | 0 | 0 |
| Other Financing Activities | (49.9) | (42.5) | (51.2) | (69.9) | 9.4 | (7.9) | (99.3) | 106.8 | (1.4) | (0.4) |
| Financing Cash Flow | (35.9) | (0.6) | 281.3 | 131.5 | (29.5) | (11.9) | (35.5) | 274.0 | 165.6 | 122.1 |
| Cash Position | ||||||||||
| Net Change in Cash | 14.5 | (45.0) | 8.3 | (139.8) | (6.6) | 213.0 | (262.4) | 93.0 | 125.3 | (11.2) |
| Cash at Beginning | 163.5 | 223.5 | 215.2 | 354.9 | 361.6 | 120.4 | 382.8 | 295.4 | 170.0 | 145.7 |
| Cash at End | 178.0 | 178.5 | 223.5 | 215.2 | 354.9 | 333.4 | 120.4 | 388.3 | 295.4 | 134.6 |
| Free Cash Flow | 4.8 | (6.1) | 113.8 | (49.9) | 13.8 | (45.7) | (78.2) | (60.2) | (55.8) | (51.0) |
| Key Metrics | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||||||
| Revenue | 1,876.2 | 2,554.7 | 1,963.9 | 1,352.0 | 908.0 | 924.6 | 687.1 | 627.1 | 434.9 | 254.2 | 96.9 | 0 | 25.7 | 8.3 |
| Gross Profit | 284.0 | 367.4 | 460.5 | 316.6 | 250.4 | 228.1 | 174.1 | 299.2 | 165.6 | 99.0 | 39.5 | 0 | (4.3) | (2.9) |
| Operating Income | (4.4) | (40.5) | (71.2) | 3.6 | (42.4) | (262.8) | (308.9) | (47.5) | (72.8) | (237.4) | (43.0) | (25.2) | (21.2) | (19.6) |
| Net Income | (534.5) | (61.6) | (113.0) | (19.2) | (37.6) | (334.2) | (302.0) | (52.7) | (60.7) | (159.7) | 332.5 | (25.2) | 20.0 | (19.3) |
| EPS (Diluted) | -5.07 | -0.81 | -1.28 | -0.20 | -0.36 | -3.94 | -3.71 | -0.68 | -0.94 | -3.55 | 7.21 | -0.66 | 0.06 | -0.50 |
| Balance Sheet | ||||||||||||||
| Cash & Equivalents | 151.9 | 104.2 | 192.8 | 188.2 | 266.3 | 333.4 | 101.0 | 228.3 | 238.4 | 134.6 | ||||
| Total Assets | 1,899.2 | 2,544.4 | 2,680.3 | 1,817.3 | 1,419.5 | 1,474.4 | 1,498.0 | 1,722.3 | 1,312.7 | 1,199.8 | ||||
| Total Debt | 989.7 | 713.7 | 644.8 | 476.1 | 280.5 | 359.8 | 368.8 | 221.0 | 121.4 | 120.3 | ||||
| Stockholders' Equity | 415.2 | 1,001.3 | 1,067.7 | 859.4 | 693.6 | 619.6 | 922.4 | 1,143.8 | 1,010.9 | 702.5 | ||||
| Cash Flow | ||||||||||||||
| Operating Cash Flow | 38.8 | 18.8 | 142.6 | (11.6) | 38.7 | (16.2) | (42.6) | (20.7) | (28.0) | (35.5) | ||||
| Capital Expenditure | (34.1) | (24.9) | (28.7) | (38.4) | (25.0) | (29.5) | (35.5) | (39.5) | (27.8) | (15.5) | ||||
| Free Cash Flow | 4.8 | (6.1) | 113.8 | (49.9) | 13.8 | (45.7) | (78.2) | (60.2) | (55.8) | (51.0) | ||||